Franchise opportunities compared

    Relive Health vs Serotonin

    Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.

    Initial investment · Item 7

    Relive Health

    Not available

    Serotonin

    $905,284 – $2,961,879

    2026 FDD · Item 7

    Initial franchise fee · Item 5

    Relive Health

    $75,000

    2026 FDD · Item 5 · PDF p. 14

    Serotonin

    $59,000

    2026 FDD · Item 5 · PDF p. 15

    Royalty · Item 6

    Relive Health

    6%

    2026 FDD · Item 6 · PDF p. 15

    Serotonin

    $7.00

    2026 FDD · Item 6 · PDF p. 17

    Before you compare

    • Both sets of figures come from 2026 FDDs.
    • Serotonin discloses more than one business format, so the investment range spans formats; the full report breaks them out.
    • Item 19 figures cover the location groups each FDD names (Relive Health: 8, Serotonin: 6). Different groups are not directly comparable.

    Financial commitment

    Estimated initial investment (Item 7)

    Relive Health

    Not available
    No reviewed Item 7 total

    Serotonin

    $905,284 – $2,961,879
    2026 FDD · Item 7
    Standard initial franchise fee (Item 5)

    Relive Health

    $75,000
    2026 FDD · Item 5 · PDF p. 14

    Serotonin

    $59,000
    2026 FDD · Item 5 · PDF p. 15
    Royalty (Item 6)

    Relive Health

    6%
    Royalty
    2026 FDD · Item 6 · PDF p. 15

    Serotonin

    $7.00
    Royalty fee
    2026 FDD · Item 6 · PDF p. 17
    Brand / advertising fund (Item 6)

    Relive Health

    $7,000
    Total Marketing Obligation
    2026 FDD · Item 6 · PDF p. 15

    Serotonin

    $2.00
    Advertising fund contribution
    2026 FDD · Item 6 · PDF p. 17

    System scale & health

    Total outlets (Item 20)

    Relive Health

    27
    Outlets at end of 2025
    2024 FDD · Item 20 · PDF p. 46

    Serotonin

    11
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 71
    Net outlet change (Item 20)

    Relive Health

    +27
    Calculated: 0 at end of 2021 → 27 at end of 2025

    Serotonin

    +7
    Calculated: 4 at end of 2023 → 11 at end of 2025
    Outlet exits (Item 20)

    Relive Health

    Not available
    No complete exit records for a year

    Serotonin

    Not available
    No complete exit records for a year
    Franchising since (Item 1)

    Relive Health

    Not available
    Not in reviewed records

    Serotonin

    Not available
    Not in reviewed records
    Franchisor founded (Item 1)

    Relive Health

    Not available
    Not in reviewed records

    Serotonin

    Not available
    Not in reviewed records

    Financial performance (Item 19), by location group

    Relive Health
    Locations counted not stated in the reviewed record — Company-owned outlets
    1 outlets
    other 2025 company-owned outlet group coverage
    2026 FDD · Item 19 · PDF p. 47
    Locations counted not stated in the reviewed record — Franchised outlets
    18 outlets
    other 2025 franchised outlet group coverage
    2026 FDD · Item 19 · PDF p. 47
    Locations counted not stated in the reviewed record — Franchised outlets excluded from 2024 representation
    10 outlets
    other 2024 excluded franchised outlets
    2026 FDD · Item 19 · PDF p. 50
    +5 more groups in the full report
    Serotonin
    Locations counted not stated in the reviewed record — Windermere affiliate-owned reporting center
    $461,094
    other Windermere gross revenue
    2026 FDD · Item 19 · PDF p. 70
    Locations counted not stated in the reviewed record — Doctor Philips affiliate-owned reporting center
    $861,789
    other Doctor Philips gross revenue
    2026 FDD · Item 19 · PDF p. 70
    Locations counted not stated in the reviewed record — Colts Neck affiliate-owned reporting center
    $1,015,054
    other Colts Neck gross revenue
    2026 FDD · Item 19 · PDF p. 70
    +3 more groups in the full report

    Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.

    Relive Health vs Serotonin: common questions

    How do Relive Health and Serotonin royalties compare?
    Relive Health: 6% (2026 FDD · Item 6 · PDF p. 15); Serotonin: $7.00 (2026 FDD · Item 6 · PDF p. 17). Royalties as disclosed in Item 6; other recurring fees are listed separately.
    Which has more locations, Relive Health or Serotonin?
    Relive Health: 27 (2024 FDD · Item 20 · PDF p. 46); Serotonin: 11 (2026 FDD · Item 20 · PDF p. 71). Total outlets from Item 20. Outlet counts do not indicate territory availability or franchisee results.
    Do Relive Health and Serotonin disclose financial performance (Item 19)?
    Relive Health has reviewed Item 19 figures for 8 location groups; Serotonin has reviewed Item 19 figures for 6 location groups. Different location groups are not directly comparable, and revenue is not profit.

    Answers restate the reviewed figures above. Not a ranking or recommendation.

    How Franopolis reviews FDD figures

    Keep researching